What is Lifecore Biomedical, Inc.'s total revenue?

Lifecore Biomedical, Inc. (LFCR) reported total revenue of $23.19M in Q1 2026.

How has Lifecore Biomedical, Inc.'s total revenue changed year-over-year?

Lifecore Biomedical, Inc.'s total revenue decreased by 36.4% year-over-year, from $36.44M to $23.19M.

What is the long-term trend for Lifecore Biomedical, Inc.'s total revenue?

Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s total revenue has grown at a 5.0% compound annual growth rate (CAGR), from $111.27M to $128.87M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Lifecore Biomedical, Inc. LFCR Total Revenue

Total Revenue at other companies

Baxter InternationalBAX

$2.7B+2.9%

Thermo Fisher ScientificTMO

$11.01B+6.2%

ADMA BiologicsADMA

$114.49M-0.3%

Medpace Holdings, Inc.MEDP

$706.6M+26.5%

Biodesix, Inc.BDSX

$25.56M+42.3%

ClearPoint NeuroCLPT

$12.13M+42.9%

Segments

By product

See full

CDMO$15.78M-32.9%

HA manufacturing$7.42M-42.6%

By segment

See full

Reportable Segment$23.19M—

Other financials

Income statement

See full

Gross profit$4.5M-68.1%

Operating income-$4.7M—

Net income-$15.0M-1,206%

EPS (diluted)-$0.43-1,333%

Balance sheet

See full

Cash & equivalents$20.8M+152%

Total debt$156.9M+1,310%

Total equity-$28.4M-2,229%

Total assets$225.5M-5.8%

Cash flow

See full

Operating cash flow$4.7M—

CapEx$1.1M-46.7%

Free cash flow$3.6M—

Valuation

See full

Market cap$196.92M-35.4%

Enterprise value$333.06M+8.3%

P/S1.6×+0.5×

Profitability

See full

Gross margin31.3%-1.4pp

Operating margin-14.5%-2.2pp

Net margin-30%—

FCF margin-36.4%—

Returns & leverage

See full

Return on equity-612.1%—

Debt / equity8.3×-1.5×

Current ratio3.8×+0.9×

Where this comes from

Reported directly by Lifecore Biomedical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Lifecore Biomedical, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s total revenue?: Lifecore Biomedical, Inc. (LFCR) reported total revenue of $23.19M in Q1 2026.
How has Lifecore Biomedical, Inc.'s total revenue changed year-over-year?: Lifecore Biomedical, Inc.'s total revenue decreased by 36.4% year-over-year, from $36.44M to $23.19M.
What is the long-term trend for Lifecore Biomedical, Inc.'s total revenue?: Over 3 years (2022 to 2025), Lifecore Biomedical, Inc.'s total revenue has grown at a 5.0% compound annual growth rate (CAGR), from $111.27M to $128.87M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.